Description

This issue of Vital Signs, released on June 15, 2009, provides a strategic overview of trends in the use of catheter ablation technologies in the treatment of Atrial Fibrillation. This information is based on Frost & Sullivan research with Electrophysiologists, General Cardiologists, and Cardiac Surgeons. Additionally, a company spotlight is provided for TomoTherapy, a developer of radiation therapy systems for the treatment of several types of cancers. Reimbursement and regulatory news from the FDA is also provided for the week of June 1-5, 2009.